Related Experiment Video
Updated: Jul 15, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
Impact of hepatitis C on HIV progression in adults with alcohol problems
Debbie M Cheng1, David Nunes, Howard Libman
1Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts 02118, USA. dmcheng@bu.edu
Insights
Hepatitis C virus (HCV) coinfection negatively impacts CD4 cell counts in human immunodeficiency virus (HIV)-infected adults with alcohol problems who adhere to antiretroviral therapy (ART). Addressing HCV may improve immune function in this population.
Area of Science:
- Infectious Diseases
- Hepatology
- Immunology
Background:
- Coinfection with HIV and HCV presents significant challenges in patient management and public health.
- Alcohol consumption can exacerbate HCV liver disease and hinder adherence to HIV treatment.
- Understanding the interplay between alcohol, HCV, and HIV progression is crucial.
Purpose of the Study:
- To investigate the association between HCV infection and markers of HIV disease progression.
- To examine how HCV coinfection affects CD4 cell counts and HIV RNA levels in adults with alcohol problems.
- To assess the impact of adherence to antiretroviral therapy (ART) on these associations.
Main Methods:
- A longitudinal study involving 396 HIV-infected adults with alcohol problems.
- Categorization based on HCV coinfection status (HCV RNA positive).
- Regular assessment of CD4 cell counts and HIV RNA levels over up to 42 months, analyzed using multivariable regression models.
Main Results:
- HCV coinfection was linked to a significantly lower CD4 cell count (-46.0 cells/microL) among patients adherent to ART (p=0.03).
- No significant association between HCV infection and CD4 cell count was found in patients not adherent to or not on ART.
- No significant association was observed between HCV infection and HIV RNA levels, irrespective of ART status.
Conclusions:
- HCV coinfection adversely affects CD4 cell counts in HIV-infected individuals with alcohol problems who are adherent to ART.
- Treating HCV coinfection in this population may lead to improved immunological outcomes.
- Targeting HCV in coinfected patients on ART could enhance immune reconstitution.
Background:
Coinfection of human immunodeficiency virus (HIV) and hepatitis C virus (HCV) is a substantial medical and public health concern due to its increasing prevalence and complex patient management. Alcohol use may worsen HCV-related liver disease and interfere with adherence to antiretroviral therapy (ART) and medical care. We therefore studied the association between HCV infection and markers of HIV disease progression in adults with alcohol problems.
Methods:
This is a longitudinal study of 396 HIV-infected persons with alcohol problems, 199 (50%) of whom were coinfected with HCV (positive HCV RNA test). CD4 cell counts and HIV RNA levels were assessed at baseline and then every 6 months for up to 42 months. Hepatitis C virus RNA status was determined at study enrollment. We examined the relationship between HCV infection and laboratory markers of HIV progression (CD4 cell count and log10 HIV RNA) by fitting multivariable longitudinal regression models for each outcome.
Results:
Among subjects who were adherent to ART, the presence of HCV infection was associated with a lower CD4 cell count (adjusted mean difference -46.0 cells/microL, p=0.03). There was no association observed between HCV infection and CD4 cell count among those not adherent to ART or those not taking ART. No significant association was observed between HCV infection and HIV RNA regardless of ART status.
Conclusions:
Hepatitis C virus infection has an adverse effect on CD4 cell count in patients with alcohol problems who are adherent to ART. Addressing HCV coinfection among these patients may confer additional immunologic benefit for this patient population.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Retrovirus Life Cycles
Cirrhosis II: Pathophysiology
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment